Mammography use for breast cancer screening in Portugal: Results from the 2005/2006 National Health Survey

European Journal of Public Health

Volumn 23, Issue 3, 2013, Pages 386-392

  Dourado, Fernanda ^a,b   Carreira, Helena ^a,b   Lunet, Nuno ^a,b  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ATTITUDE TO HEALTH; BODY MASS; BREAST NEOPLASMS; CLUSTER ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; EARLY DIAGNOSIS; EPIDEMIOLOGY; FEMALE; HEALTH CARE DELIVERY; HEALTH SURVEY; HUMAN; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PORTUGAL; PSYCHOLOGY; PUBLIC HEALTH; QUESTIONNAIRE; SMOKING; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TIME; UTILIZATION;

ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PORTUGAL; QUESTIONNAIRES; RESIDENCE CHARACTERISTICS; SMOKING; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 84878316797     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cks103     Document Type: Review

References (35)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Hakama M, Coleman MP, Alexe DM, Auvinen A. Cancer screening: evidence and practice in Europe 2008. Eur J Cancer 2008;44:1404-13.
3. Karim-Kos HE, de Vries E, Soerjomataram I, et al. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345-89.
4. Perry N, Broeders M, de Wolf C, et al. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition-summary document. Ann Oncol 2008;19:614-22.
5. Busse R, Blumel M, Scheller-Kreinsen D, Zentner A. Tackling chronic disease in Europe: strategies, interventions and challenges. World Health Organization and European Observatory on Health Systems and Policies, 2010.
6. Bastos J, Peleteiro B, Gouveia J, et al. The state of the art of cancer control in 30 European countries in 2008. Int J Cancer 2010;126:2700-15.
7. Ministério da Saúde-Administração Regional de Saúde do Centro IP. Relatório de Actividades, 2010.
8. Ministério da Saúde-Alto Comissariado da Saúde. Doenças oncológicas em Portugal. Boletim Informativo n-4/Abril 2009. Gabinete de Informação e Prospectiva, 2009.
9. Aubard Y, Genet D, Eyraud JL, et al. Impact of screening on breast cancer detection. Retrospective comparative study of two periods ten years apart. Eur J Gynaecol Oncol 2002;23:37-41.
10. Anderson BO, Jakesz R. Breast cancer issues in developing countries: an overview of the Breast Health Global Initiative. World J Surg 2008;32:2578-85.
11. Ministério da Saúde-Alto Comissariado da Saúde, Coordenação Nacional para as Doenças Oncológicas. Plano Nacional de Prevenção e Controlo das Doenças Oncológicas 2007/2010 (PNPCDO). Orientações programáticas, 2007.
12. Bastos J, Barros H, Lunet N. [Breast cancer mortality trend in Portugal (1955-2002)]. Acta Med Port 2007;20:139-44.
13. Ministério da Saúde-Administração Regional de Saúde do Algarve IP. Relatório preliminar da 2a volta do Programa de Rastreio do Cancro da Mama no Algarve, 2010.
14. Ministério da Saúde-Administração Regional de Saúde do Norte IP. Relatório de Actividades, 2009.
15. Wang H, Karesen R, Hervik A, Thoresen SO. Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening. Cancer Causes Control 2001;12:39-45.
16. Alves C, Alves L, Lunet N. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women. Eur J Cancer Prev 2009;18:482-8.
17. Associação Oncológica do Algarve. Rastreio do Cancro da Mama no Algarve. Available at: http://aoa.pt/index.php?option=com- content&view=article&catid=54&id=94&Itemid=91(30 July 2012, date last accessed).
18. Bancej CM, Maxwell CJ, Snider J. Inconsistent self-reported mammography history: findings from the National Population Health Survey longitudinal cohort. BMC Health Serv Res 2004;4:32.
19. Rohlfs I, Borrell C, Pararín M, Plaséncia A. The role of sociodemographic factors in preventive practices: the case of cervical and breast cancer. Eur J Public Health 1999; 9:278-84.
20. Martin-Lopez R, Hernandez-Barrera V, De Andres AL, et al. Breast and cervical cancer screening in Spain and predictors of adherence. Eur J Cancer Prev 2010;19: 239-45.
21. Croswell JM, Ransohoff DF, Kramer BS. Principles of cancer screening: lessons from history and study design issues. Semin Oncol 2010;37:202-15.
22. Hsia J, Kemper E, Kiefe C, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med 2000;31:261-70.
23. Duport N, Ancelle-Park R, Boussac-Zarebska M, et al. Are breast cancer screening practices associated with sociodemographic status and healthcare access? Analysis of a French cross-sectional study. Eur J Cancer Prev 2008;17:218-24.
24. Pires C, Tura LF, Costa N, Duarte J. A population-based breast cancer screening programme: conducting a comprehensive survey to explore adherence determinants. Eur J Cancer Care (Engl) 2012;21:349-59.
25. Lagerlund M, Sparen P, Thurfjell E, et al. Predictors of non-attendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev 2000;9:25-33.
26. Poole B, Black C, Gelmon K, Kan L. Is Canadian women's breast cancer screening behaviour associated with having a family doctor? Can Fam Physician 2010;56: e150-7.
27. Barroso Garcia P, Ruiz Perez I, de Rojas FP, et al. [Factors related to non-participation in a breast cancer early detection program]. Gac Sanit 2009;23: 44-8.
28. Alcaraz M, Lluch A, Miranda J, et al. [Study of non-participation in the breast cancer screening program in the city of Valencia (Spain)]. Gac Sanit 2002;16:230-5.
29. von Euler-Chelpin M, Olsen AH, Njor S, et al. Socio-demographic determinants of participation in mammography screening. Int J Cancer 2008;122:418-23.
30. Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med 2000; 132:697-704.
31. Edwards SA, Chiarelli AM, Stewart L, et al. Predisposing factors associated with compliance to biennial breast screening among centers with and without nurses. Cancer Epidemiol Biomarkers Prev 2009;18:739-47.
32. Qi V, Phillips SP, Hopman WM. Determinants of a healthy lifestyle and use of preventive screening in Canada. BMC Public Health 2006;6:275.
33. Barnett GC, Shah M, Redman K, et al. Risk factors for the incidence of breast cancer: do they affect survival from the disease? J Clin Oncol 2008;26:3310-6.
34. Potvin L, Camirand J, Beland F. Patterns of health services utilization and mammography use among women aged 50 to 59 years in the Quebec Medicare system. Med Care 1995;33:515-30.
35. Bare ML, Montes J, Florensa R, et al. Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 2003;12: 487-94.